Lenalidomide API CAS NO.847871-99-2

API grade with GMP certification 

Could provide for finished formulation R&D and provide registration support 

We could meet the order from lab to commercial quantity, and technical pacakge is available for long-term cooperation 

Bocimed does not sell compounds in the period of patent protection. According to the relevant provisions of the patent law, "the act of importing, manufacturing and using patented drugs by others before the expiration of drug patents without the consent of the patentee in order to obtain the data and other information required by the drug administration department shall be not regarded as infringing the patent right".

Lenalidomide API

CAS 847871-99-2

Purity ≥ 99%

Shanghai Bocimed Pharmaceutical Co., Ltd. (Bocimed) is a technology enterprise specializing in pharmaceutical research, which was established in Zhangjiang Pharmaceutical Valley of Shanghai in 2012. Bocimed has Zhangjiang R & D headquarter, Lingang production base and Chengdu clinical subsidiary. With the unique platform advantages of solubilization technology, sustained-release technology and nanotechnology, the company is committed to become a leading enterprise in the development and production of innovative and special preparations, and realize the vision of bringing better drugs to the world.

Bocimed does not sell compounds in the period of patent protection. According to the relevant provisions of the patent law, "the act of importing, manufacturing and using patented drugs by others before the expiration of drug patents without the consent of the patentee in order to obtain the data and other information required by the drug administration department shall be not regarded as infringing the patent right".